Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.

نویسندگان

  • Fayna Diaz-San Segundo
  • Camila C A Dias
  • Mauro P Moraes
  • Marcelo Weiss
  • Eva Perez-Martin
  • Gary Owens
  • Max Custer
  • Kurt Kamrud
  • Teresa de los Santos
  • Marvin J Grubman
چکیده

We have previously shown that delivery of the porcine type I interferon gene (poIFN-α/β) with a replication-defective human adenovirus vector (adenovirus 5 [Ad5]) can sterilely protect swine challenged with foot-and-mouth disease virus (FMDV) 1 day later. However, the need of relatively high doses of Ad5 limits the applicability of such a control strategy in the livestock industry. Venezuelan equine encephalitis virus (VEE) empty replicon particles (VRPs) can induce rapid protection of mice against either homologous or, in some cases, heterologous virus challenge. As an alternative approach to induce rapid protection against FMDV, we have examined the ability of VRPs containing either the gene for green fluorescent protein (VRP-GFP) or poIFN-α (VRP-poIFN-α) to block FMDV replication in vitro and in vivo. Pretreatment of swine or bovine cell lines with either VRP significantly inhibited subsequent infection with FMDV as early as 6 h after treatment and for at least 120 h posttreatment. Furthermore, mice pretreated with either 10(7) or 10(8) infectious units of VRP-GFP and challenged with a lethal dose of FMDV 24 h later were protected from death. Protection was induced as early as 6 h after treatment and lasted for at least 48 h and correlated with induction of an antiviral response and production of IFN-α. By 6 h after treatment several genes were upregulated, and the number of genes and the level of induction increased at 24 h. Finally, we demonstrated that the chemokine IP-10, which is induced by IFN-α and VRP-GFP, is directly involved in protection against FMDV.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

The development of multiagent vaccines offers the advantage of eliciting protection against multiple diseases with minimal inoculations over a shorter time span. We report here the results of using formulations of individual Venezuelan equine encephalitis (VEE) virus replicon-vectored vaccines against a bacterial disease, anthrax; a viral disease, Marburg fever; and against a toxin-mediated dis...

متن کامل

Mice and Cotton Rats Induce Protective Mucosal Responses in Syncytial Virus Surface Glycoproteins Replicon Particles Encoding Respiratory Venezuelan Equine Encephalitis Virus

Published Ahead of Print 10 October 2007. 2007, 81(24):13710. DOI: 10.1128/JVI.01351-07. J. Virol. Robert E. Johnston and James E. Crowe Jr. Vasiliy V. Polosukhin, Martha L. Collier, Nancy L. Davis, Hoyin Mok, Sujin Lee, Thomas J. Utley, Bryan E. Shepherd, Mice and Cotton Rats Induce Protective Mucosal Responses in Syncytial Virus Surface Glycoproteins Replicon Particles Encoding Respiratory Ve...

متن کامل

Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.

The etiological role of human papillomaviruses (HPV) in cervical and other cancers suggests that therapeutic vaccines directed against requisite viral antigens may eradicate tumors or their precursors. A Venezuelan equine encephalitis (VEE) alphavirus vector delivering the HPV16 E7 RNA was evaluated for antitumor efficacy using a murine E7+ tumor model. Vaccination with VEE replicon particles e...

متن کامل

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

There are no vaccines or therapeutics currently approved for the prevention or treatment of ebolavirus infection. Previously, a replicon vaccine based on Venezuelan equine encephalitis virus (VEEV) demonstrated protective efficacy against Marburg virus in nonhuman primates. Here, we report the protective efficacy of Sudan virus (SUDV)- and Ebola virus (EBOV)-specific VEEV replicon particle (VRP...

متن کامل

Characterization of Dendritic Cells Transduced with Venezuelan Equine Encephalitis Virus Replicon Particles as Therapeutic Cancer Vaccines

TIMOTHY P. MORAN: Characterization of Dendritic Cells Transduced with Venezuelan Equine Encephalitis Virus Replicon Particles as Therapeutic Cancer Vaccines (Under the direction of Jonathan S. Serody and Robert E. Johnston) Cancer vaccines seek to harness the specificity of T and B lymphocytes for reduction of tumor burden, as well as prevention of recurrent disease by establishing immunologica...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of virology

دوره 87 10  شماره 

صفحات  -

تاریخ انتشار 2013